Stay updated with breaking news from Expanded Access Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
14.12.2021 - Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today ... Seite 1
Hong Kong, Shanghai & Florham Park, NJ — Friday, December 10, 2021: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new analyses and updates on the ongoing studies of surufatinib combined with toripalimab, in multiple disease settings, presented at the Europ...
NRx and Hungary Agree on Regulatory Path for Emergency Use of ZYESAMI Hungary to Serve as First European Nation for the Registrational Phase 2b/3 BriLife COVID Vaccine Trial
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
NRx and Hungary Agree on Regulatory Path for Emergency Use of ZYESAMIHungary to Serve as First European Nation for the Registrational Phase 2b/3 BriLife...